Loading viewer...
annual_report
Format: PDF annual_report
Alzamend Neuro, Inc. (NASDAQ: ALZN) is a biotech company filing its annual report for fiscal year ended April 30, 2023. The company operates from Atlanta, Georgia and is classified as a non-accelerated filer, smaller reporting company, and emerging growth company.
annual_report
105 Pages
annual_report
111 Pages
Unknown
annual_report
Vion
annual_report
BG Group
Allianz Malaysia 46th Annual General Meeting 2020
annual_reportannual_report
33 Pages
Allianz Malaysia Berhad